MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical ...

A world where hospitals never run out of critical medicines, retail stores always have the right seasonal products in stock, ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

With the support of AI, AIM Vaccine is rapidly advancing multiple blockbuster products, including the mRNA shingles vaccine, mRNA RSV vaccine, and mRNA influenza vaccine. This not only reflects the ...

Dr Sanjay Agrawal, a renowned pharmaceutical consultant and scientific advisor of Alkomex GBN Pharma Group USA, has recently applied for a patent for an anti-aging formulation. Dr Agrawal has ...

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from ... working to accelerate the development of vaccines to ...

AI can deliver huge benefits to chemistry, but some also worry about the turbulence it might bring to the job market ...

Relmada continues to evaluate additional product and strategic opportunities. The Company anticipates hosting an investor update on Sepranolone’s next development steps later in 2025.

Only when pharma companies seize the initiative and align their product development with the unmet needs of all stakeholders will brands successfully navigate the new demands of market access ...